These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17911378)

  • 1. Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
    Yamauchi C; Mitsumori M; Sai H; Imagunbai T; Negoro Y; Sasaki Y; Hiraoka M; Shikama N; Sasaki S; Takegawa H; Inoue T; Teshima T
    Jpn J Clin Oncol; 2007 Oct; 37(10):737-43. PubMed ID: 17911378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patterns of care study for breast-conserving therapy in Japan: analysis of process survey from 1995 to 1997.
    Mitsumori M; Hiraoka M; Negoro Y; Yamauchi C; Shikama N; Sasaki S; Yamamoto T; Teshima T; Inoue T
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1048-54. PubMed ID: 15990008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care study for postmastectomy radiotherapy in Japan: its role in monitoring the patterns of changes in practice.
    Shikama N; Mitsumori M; Yamauchi C; Takekawa H; Arakawa K; Sasaki S; Teshima T
    Jpn J Clin Oncol; 2006 Aug; 36(8):499-503. PubMed ID: 16803842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
    Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
    Toita T; Nakamura K; Uno T; Kodaira T; Shinoda A; Ogawa K; Mitsuhashi N; Maebayashi K; Kawaguchi A; Inoue T; Teshima T
    Jpn J Clin Oncol; 2005 Mar; 35(3):139-48. PubMed ID: 15741304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; Van Dijck JA; Wobbes T
    Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with breast-conservation standards for patients with early-stage breast carcinoma.
    White J; Morrow M; Moughan J; Owen J; Pajak T; DesHarnais S; Winchester DP; Wilson JF; ;
    Cancer; 2003 Feb; 97(4):893-904. PubMed ID: 12569588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast conservation surgery--the surgeon's factor.
    Woon YY; Chan MY
    Breast; 2005 Apr; 14(2):131-5. PubMed ID: 15767182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
    Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of early breast carcinoma before and after the introduction of clinical practice guidelines.
    White V; Pruden M; Giles G; Collins J; Jamrozik K; Inglis G; Boyages J; Hill D
    Cancer; 2004 Aug; 101(3):476-85. PubMed ID: 15274060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of breast-conserving therapy in a predominantly rural population: need for improved surgeon and public education.
    Hokanson P; Seshadri R; Miller KD
    Clin Breast Cancer; 2000 Apr; 1(1):72-6. PubMed ID: 11899394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.
    Gutierrez JC; Hurley JD; Housri N; Perez EA; Byrne MM; Koniaris LG
    Ann Surg; 2008 Aug; 248(2):154-62. PubMed ID: 18650623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
    Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G
    J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
    Antonini N; Jones H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Jager J; Hoogenraad W; Collette L; Pierart M; Hart G; Bartelink H
    Radiother Oncol; 2007 Mar; 82(3):265-71. PubMed ID: 17126434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician practice volume and alternative surgical treatment for breast cancer in Florida.
    Luther SL; Studnicki J
    Health Serv Res; 2001 Dec; 36(6 Pt 2):166-79. PubMed ID: 16148967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
    Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications and limits of breast conserving treatment].
    Takahashi K; Nishimura S; Tada K; Saito M; Makita M; Tada T; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1125-31. PubMed ID: 12145991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.